Document Detail


Giant cell arteritis: diagnosis, management, and cardiovascular implications.
MedLine Citation:
PMID:  17303991     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Giant cell arteritis is a relatively common form of systemic vasculitis, best known for its predisposition to affect the extracranial branches of the carotid artery and associated potential for visual loss. Additional vascular manifestations include stroke, aortic aneurysm or dissection, and even aortic rupture. Cardiac manifestations include coronary artery disease, aortic valve insufficiency, or left ventricular dysfunction, which may occur independently from the valvular disease or hypertension. Physicians need to be vigilant for this disorder, particularly because the tragic end-organ outcomes such as visual loss can be effectively prevented with early use of corticosteroids. We review the pathophysiology and clinical manifestations of giant cell arteritis and present a rationale for diagnosis and therapy for this disease.
Authors:
Robert T Eberhardt; Mandeep Dhadly
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Cardiology in review     Volume:  15     ISSN:  1538-4683     ISO Abbreviation:  Cardiol Rev     Publication Date:    2007 Mar-Apr
Date Detail:
Created Date:  2007-02-16     Completed Date:  2007-03-13     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  9304686     Medline TA:  Cardiol Rev     Country:  United States    
Other Details:
Languages:  eng     Pagination:  55-61     Citation Subset:  IM    
Affiliation:
Vascular Medicine Program, Division of Cardiovascular Medicine, Department of Medicine, Boston University School of Medicine, Boston, Massachusetts, USA. robert.eberhardt@bmc.org
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adrenal Cortex Hormones / therapeutic use
Adult
Age Distribution
Aged
Diagnosis, Differential
Europe / epidemiology
Female
Giant Cell Arteritis / diagnosis*,  epidemiology,  physiopathology,  therapy*
Humans
Immunosuppressive Agents / therapeutic use
Incidence
Male
Middle Aged
Prognosis
Sex Distribution
Takayasu Arteritis / diagnosis,  epidemiology
Temporal Arteries / pathology,  radionuclide imaging,  ultrasonography
Chemical
Reg. No./Substance:
0/Adrenal Cortex Hormones; 0/Immunosuppressive Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Clinical assessment of the DINAMAP ProCare monitor in an adult population according to the British H...
Next Document:  The effect of diet on endothelial function.